Peripheral cytokines profile in Parkinson's disease
1Department of Oncology and Neuroscience, University G. D'Annunzio Chieti-Pescara, Italy. mreale@unich.it
Brain, Behavior, and Immunity
|August 6, 2008
Summary
Parkinson's disease (PD) patients show elevated proinflammatory cytokines in peripheral blood mononuclear cells (PBMCs). These elevated cyto/chemokine levels correlate with disease severity, indicating peripheral immune dysregulation in PD.
Area of Science:
- Neuroimmunology
- Parkinson's Disease Research
- Cytokine Biology
Background:
- Inflammation and elevated proinflammatory cytokines are implicated in Parkinson's disease (PD) neurodegeneration.
- Microglial activation in PD leads to blood-brain barrier (BBB) dysfunction and immune cell recruitment.
- Systemic inflammation and circulating cytokines may influence neuronal communication and immune activity.
Purpose of the Study:
- To investigate the levels of cyto/chemokines produced by peripheral blood mononuclear cells (PBMCs) in PD patients.
- To determine the correlation between these peripheral immune markers and PD clinical severity.
- To explore the relationship between NF-kappaBp65, cyto/chemokines, and disease progression.
Main Methods:
- Quantitative analysis of basal and lipopolysaccharide (LPS)-induced cyto/chemokine levels (MCP-1, RANTES, MIP-1alpha, IL-8, IFNgamma, IL-1beta, TNFalpha) using RT-PCR and Elisa.
- Correlation analysis using Pearson's correlation coefficient (R) to assess relationships between cyto/chemokine levels, NF-kappaBp65, and clinical scores (UPDRS III, H/Y stage).
Main Results:
- PD patients exhibited significantly higher basal and LPS-induced levels of multiple cyto/chemokines compared to healthy controls (HC).
- Elevated cyto/chemokine levels were significantly correlated with the Unified Parkinson's Disease Rating Scale III (UPDRS III) and Hoehn/Yahr (H/Y) stage.
- The study identified significant correlations between NF-kappaBp65 levels and both studied cyto/chemokines and clinical PD severity scores.
Conclusions:
- The findings confirm peripheral immune system dysregulation in the cytokine network of PD patients.
- Peripheral cyto/chemokine profiles are associated with PD progression and clinical manifestation.
- This study enhances the understanding of the interplay between peripheral inflammation and neurodegeneration in Parkinson's disease.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...